stars 1 stars 2 stars 3

Symbioken is a French start-up company created in 2011. Symbioken has developed a device, named AmeaCell®, to be used by esthetic surgeons for their patients for wrinkles filling. AmeaCell® allows the extraction of both stem cells and matrix from the patient, for re-injection into the same patient’s face wrinkles for filling them and skin repair. The device is currently under clinical investigation.

SYMBIOKEN Questions

The SYMBIOKEN annual revenue was $4 million in 2026.

2 people are employed at SYMBIOKEN.

SYMBIOKEN is based in Toulouse, Occitania.

The NAICS codes for SYMBIOKEN are [54171, 541, 54, 5417, 541713].

The SIC codes for SYMBIOKEN are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users